Literature DB >> 11849996

Ribosomal scanning on the highly structured insulin-like growth factor II-leader 1.

Alike W van der Velden1, Kirsten van Nierop, Harry O Voorma, Adri A M Thomas.   

Abstract

The complex architecture of human insulin-like growth factor (IGF) II-leader 1 of 592 nucleotides (nt), with one open reading frame (ORF), and the potential to fold into stable structures makes efficient linear ribosomal scanning difficult to comprehend. Indeed, leader 1-driven reporter expression is low in rabbit reticulocyte lysate. Contrarily, leader 1 is very efficient in cells. Therefore, we tested whether this 5'UTR uses an alternative mechanism for translation initiation in vivo, internal entry or ribosomal shunting. Internal initiation was tested by introducing leader 1 into the intercistronic region of a bicistronic vector. Second cistron expression, driven by leader 1, was lower than by the intercistronic beta-globin 5'UTR, indicating that leader 1 does not contain an internal ribosomal entry site (IRES). Shunting was tested by inserting hairpin (HP) structures, capable of blocking ribosomal scanning, at eight positions in leader 1. After transfection, these mutant 5'UTRs were incapable of directing reporter expression. Less stable HPs at the same positions increased the activity to 50% of wild-type activity, indicating that insertions at these positions are not disastrous for initiation. These data indicate that the translational machinery encounters major parts of leader 1. As scanning seems unlikely, and internal entry and shunting were shown not to occur, we discuss a modified scanning mechanism for architecturally complex 5'UTRs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849996     DOI: 10.1016/s1357-2725(01)00116-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Discontinuous subgenomic RNA synthesis in arteriviruses is guided by an RNA hairpin structure located in the genomic leader region.

Authors:  Erwin van den Born; Clara C Posthuma; Alexander P Gultyaev; Eric J Snijder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Looking for organization patterns of highly expressed genes: purine-pyrimidine composition of precursor mRNAs.

Authors:  A Paz; D Mester; E Nevo; A Korol
Journal:  J Mol Evol       Date:  2007-01-08       Impact factor: 2.395

3.  Efficient translation initiation directed by the 900-nucleotide-long and GC-rich 5' untranslated region of the human retrotransposon LINE-1 mRNA is strictly cap dependent rather than internal ribosome entry site mediated.

Authors:  Sergey E Dmitriev; Dmitri E Andreev; Ilya M Terenin; Ivan A Olovnikov; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

4.  Re-engineering multicloning sites for function and convenience.

Authors:  Nathan C Crook; Elizabeth S Freeman; Hal S Alper
Journal:  Nucleic Acids Res       Date:  2011-05-17       Impact factor: 16.971

5.  Ribosomal scanning on the 5'-untranslated region of the human immunodeficiency virus RNA genome.

Authors:  Ben Berkhout; Kelly Arts; Truus E M Abbink
Journal:  Nucleic Acids Res       Date:  2011-03-09       Impact factor: 16.971

Review 6.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

7.  Differential contribution of the m7G-cap to the 5' end-dependent translation initiation of mammalian mRNAs.

Authors:  Dmitri E Andreev; Sergey E Dmitriev; Ilya M Terenin; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

Review 8.  Current Practice in Bicistronic IRES Reporter Use: A Systematic Review.

Authors:  Guus Gijsbertus Hubert van den Akker; Federico Zacchini; Bas Adrianus Catharina Housmans; Laura van der Vloet; Marjolein Maria Johanna Caron; Lorenzo Montanaro; Tim Johannes Maria Welting
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.